Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

437 Press Releases
DateTitleCompany
25 Jun 14 LEADING DRUGS INDUSTRY ACQUISITIONS EXPERT SAYS ASTRAZENECA TAKEOVER COULD BE GOOD NEWS FOR NHS DR STEVEN BRADSHAW URGES CRITICS TO SEE BENEFITS - TO STAKEHOLDERS, HEALTHCARE PROVIDERS AND PATIENTS AstraZeneca,
Published by
Kudos PR
25 Jun 14 Simbec Research Limited (“Simbec”) and ORION Clinical Services Limited (“ORION”) Simbec Research
25 Jun 14 PolyPid Wins First Prize at Biomed Startup Competition PolyPid,
Published by
Kanaan Public Relations
25 Jun 14 ONYX TO INVEST IN CONTINUOUS FLOW TECHNOLOGY Onyx Scientific
24 Jun 14 ACLS Online Course Materials are Now Available for an Unlimited Time on ACLS-PALS-BLS.com IREACH HOUSE ACCOUNT,
Published by
PR Newswire
23 Jun 14 Aesica Pharmaceuticals S.r.I. collaborates with QAD to meet China’s Food and Drug Administration’s shortened serialisation deadline Aesica Pharmaceuticals
23 Jun 14 GenSpera, Inc. (GNSZ) Releases Updated Corporate Video: "GenSpera has targeted its active ingredient thapsigargin to kill only the cells we select: cancer" PR NEWSWIRE EUROPE,
Published by
PR Newswire
23 Jun 14 Spring Bank Pharmaceuticals Presents at the Nucleic Acid Summit 2014 SPRING BANK PHARAMCEUTICALS INC.,
Published by
PR Newswire
23 Jun 14 Shire Launches Excellence in ADHD Patient Group Awards Shire plc
23 Jun 14 ABLYNX WINS TRANSACTION OF THE YEAR AT THE 2014 EUROPEAN MEDISCIENCE AWARDS Ablynx
23 Jun 14 Shire to Host Investor Call Shire plc,
Published by
PR Newswire
19 Jun 14 Cardiome to Present at JMP Securities Healthcare Investor Conference Cardiome Pharma Corp.,
Published by
PR Newswire
19 Jun 14 New Cetraben® lotion – a convenient leave-on emollient launched by Thornton & Ross Thornton & Ross,
Published by
PharmiWeb.com
19 Jun 14 Study findings show tiotropium Respimat®* well-tolerated and effective in Japanese patients with symptomatic asthma NATIONAL Public Relations - Toronto,
Published by
PR Newswire
18 Jun 14 UCR (Uppsala Clinical Research Center) selected Ethical eAdjudication® to Support the Clinical Endpoints Adjudication Process Ethical GmbH
18 Jun 14 UK NICE to hold oral appeal hearing for FIRMAGON® (degarelix) for the treatment of advanced hormone-dependent prostate cancer Ferring Pharmaceuticals
18 Jun 14 Recipharm and CTC forms new collaboration Recipharm
17 Jun 14 Coming to Europe- Best Pharma Market Research Conference: Oct 21-22, 2014, Germany Pharma Market Research Conference
17 Jun 14 Global 5-Hydroxytryptophan (5-HTP) Market for Food and Beverage, Dietary Supplements, Medical and Other Applications - Forecasts to 2019 RESEARCH AND MARKETS,
Published by
PR Newswire
17 Jun 14 Colombia is an Attractive Emerging Pharmaceutical Market That is Expected to Grow at a Compound Annual Rate of 7.3 Percent Between 2013 and 2016 DECISION RESOURCES GROUP,
Published by
PR Newswire
17 Jun 14 Largest Ever Head to Head Comparison of Targeted Therapy for advanced bowel cancer reports at 50th ASCO Congress Merck Serono
17 Jun 14 Merck Millipore Launches Simplicon™ RNA Reprogramming Technology for Efficient Generation of Virus-Free iPSCs Merck Millipore,
Published by
PharmiWeb.com
17 Jun 14 New one-year data of IDegLira shows glucose-lowering effect was maintained for people with type 2 diabetes Novo Nordisk
17 Jun 14 New phase 3 study shows efficacy and safety of Victoza® for the treatment of type 2 diabetes in adults with moderate renal impairment Novo Nordisk
17 Jun 14 Penn Pharma receives multiple awards at the BVCA Management Team Awards 2014 Penn Pharma,
Published by
Remarkable PR
17 Jun 14 Tresiba® (insulin degludec) achieves significantly lower rate of nocturnal hypoglycaemia compared to insulin glargine in type 2 diabetes Novo Nordisk,
Published by
Pegasus
17 Jun 14 European Medicines Agency Validates Marketing Authorization Applications for AbbVie's Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 1 Chronic Hepatitis C ABBVIE INC.,
Published by
PR Newswire
16 Jun 14 Latest data demonstrate sustained results of Bydureon® (exenatide once-weekly) treatment over six years in type 2 diabetes patients AstraZeneca
16 Jun 14 PAREXEL Cuts Clinical Trial Start-Up Time For Sponsors By Weeks With New Version Of Industry-Leading ClinPhone® RTSM Services PAREXEL/PAREXEL INTERNATIONAL LLC,
Published by
PR Newswire
16 Jun 14 Avion Pharmaceuticals, LLC, Announces positive feedback from the FDA on two New Drug Applications ACELLA PHARMACEUTICALS LLC,
Published by
PR Newswire
Advertising